Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 9;317(1):209.
doi: 10.1007/s00403-024-03751-1.

Melanoma detection, treatment, survival, and mortality through year 2 of the pandemic

Uriel Kim  1   2   3   4 , Richard S Hoehn  5   6   7 , Siran M Koroukian  5   8   6   9 , Johnie Rose  5   8   6   9 , Jeremy S Bordeaux  5   6   10 , Bryan T Carroll  5   6   10
Affiliations

Melanoma detection, treatment, survival, and mortality through year 2 of the pandemic

Uriel Kim et al. Arch Dermatol Res. .

Abstract

The COVID-19 pandemic affected the timely diagnosis and treatment of many cancers, including melanoma, the fifth most common cancer in the U.S. This study aimed to quantify the disruption and recovery of melanoma detection, treatment, survival, and mortality during the pandemic by analyzing data from the Surveillance, Epidemiology, and End Results (SEER) program from 2000 to 2021. Our epidemiological analysis found that melanoma incidence initially dropped by 14.8% (95% CI: - 17.2 to - 12.4) in 2020 compared to pre-pandemic projections. Although incidence rates substantially recovered by 2021, an estimated 10,274 patients (95% CI: - 12,824 to - 7,724) remained undiagnosed due to pandemic-related disruptions. Time-to-treatment and 1-year survival were mostly consistent with pre-pandemic trends, while melanoma-specific mortality modestly declined by 4.5% (95% CI: - 14.6 to 5.6) in 2021, though this was statistically non-significant. These findings suggest that healthcare systems adapted to the challenges posed by the pandemic, maintaining essential cancer services. However, the significant drop in melanoma diagnoses likely contributed to the observed reduction in mortality. Thus, re-establishing care for patients missed during the pandemic will be crucial to preventing a future increase in advanced-stage melanoma and related deaths.

Keywords: COVID-19; Incidence; Melanoma; Mortality; Survival.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors have no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Disruption and recovery of melanoma incidence during the COVID-19 pandemic
Fig. 2
Fig. 2
Observed and expected mean time to treatment during year 1 (2020) and year 2 (2021) of the pandemic
Fig. 3
Fig. 3
Observed and expected mortality among patients with metastatic melanoma who die within year of diagnosis
See this image and copyright information in PMC

References

    1. Kim U, Koroukian S, Rose J, Hoehn RS, Carroll BT (2024) US cancer detection decreased nearly 9% during the first year of the COVID-19 pandemic. Health Aff 43(1):125–130. 10.1377/hlthaff.2023.00767 - DOI - PubMed
    1. Kim U, Rose J, Carroll BT et al (2024) Recovery from COVID-19–related disruptions in cancer detection. JAMA Netw Open 7(10):e2439263–e2439263. 10.1001/jamanetworkopen.2024.39263 - DOI - PMC - PubMed
    1. Burus T, Lei F, Huang B et al (2024) COVID-19 and rates of cancer diagnosis in the US. JAMA Netw Open 7(9):e2432288–e2432288. 10.1001/jamanetworkopen.2024.32288 - DOI - PMC - PubMed
    1. Huang L, Midthune D, Krapcho M, Zou Z, Horner M-J, Feuer EJ (2013) Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries. Biom J 55(5):755–770. 10.1002/bimj.201100191 - DOI - PubMed
    1. Midthune DN, Fay MP, Clegg LX, Feuer EJ (2005) Modeling reporting delays and reporting corrections in cancer registry data. J Am Stat Assoc 100(469):61–70. 10.1198/016214504000001899 - DOI

MeSH terms

LinkOut - more resources